A Formulation Scientist plays a vital role in the development of safe and effective therapeutic products. Their primary responsibility is to design and optimize the composition of drugs to ensure stability, bioavailability, and patient compliance. This involves selecting suitable excipients, determining the right dosage form (such as tablets, capsules, or injectables), and understanding the physicochemical properties of active pharmaceutical ingredients. The goal is to create a product that delivers the desired therapeutic effect consistently and reliably over its shelf life. These professionals also conduct rigorous compatibility and stability testing under various environmental conditions to guarantee product integrity. Their work ensures not only the quality of the medication but also its effectiveness and ease of administration. Innovation is also key, as they may explore new delivery systems like nanocarriers or controlled-release mechanisms.
Formulation Scientist collaborates closely with analytical chemists, process engineers, and regulatory teams throughout the development lifecycle. They must consider factors like manufacturability, scalability, and regulatory compliance, ensuring the final product meets global health standards. They contribute to drafting technical documents and supporting regulatory submissions, playing a crucial role in bringing new treatments from concept to market. With advances in biotechnology, personalized medicine, and novel drug delivery systems, the role continues to evolve—demanding not only scientific expertise but also innovation and adaptability in a highly regulated and competitive environment.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico